Article
Two clinical subgroups of immune checkpoint inhibitor-induced inflammatory arthritis determined by latent class analysis.
Seminars in arthritis and rheumatism - 1 Oct 2025
Cappelli Laura C, Perin Jamie, Zeger Scott, Jones Michelle, Bingham Clifton O, Shah Ami A
Abstract excerpt
BACKGROUND: Immune checkpoint inhibitors (ICI) for cancer treatment can cause inflammatory arthritis (IA). Since ICI-IA has a unique pathogenesis, applying categories of traditional IA may be of limited use. METHODS: Participants were ≥18 years old, treated with anti-PD-1, anti-PD-L1, and/or anti-CTLA-4 agents, and had ICI-IA diagnosed by a rheumatologist. We clustered patients using latent class analysis (LCA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
